GENIISYS™ underpins our three distinct, but synergistic business lines, which converge to deliver on the promise and power of equalizing precision medicine for all.
These business lines – drug discovery, molecular diagnostics, and clinical trial programs – are specifically inclusive of African populations, which demonstrates 54gene’s Commitment to Africa and Partnering with other mission-driven organizations seeking to enable global access of precision medicine for all.